FSA
ABBV icon

Financial Sense Advisors’s AbbVie ABBV Stock Holding History

Financial Sense Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$654K Sell
3,008
-1
-0% -$222 0.13% 90
2025
Q4 		$688K Sell
3,009
-1,715
-36% -$391K 0.13% 92
2025
Q3 		$1.09M Sell
4,724
-118
-2% -$24K 0.19% 75
2025
Q2 		$899K Sell
4,842
-233
-5% -$43.3K 0.21% 68
2025
Q1 		$1.06M Sell
5,075
-11,875
-70% -$2.31M 0.3% 52
2024
Q4 		$3.01M Sell
16,950
-749
-4% -$138K 1% 28
2024
Q3 		$3.5M Sell
17,699
-269
-1% -$50.2K 0.95% 23
2024
Q2 		$3.08M Buy
17,968
+5,443
+43% +$902K 0.94% 27
2024
Q1 		$2.28M Sell
12,525
-865
-6% -$149K 0.75% 36
2023
Q4 		$2.08M Buy
13,390
+764
+6% +$111K 0.77% 33
2023
Q3 		$1.88M Sell
12,626
-3,869
-23% -$568K 0.8% 34
2023
Q2 		$2.22M Buy
16,495
+1,311
+9% +$192K 0.94% 32
2023
Q1 		$2.42M Buy
15,184
+206
+1% +$31.5K 1.07% 31
2022
Q4 		$2.42M Buy
14,978
+2,502
+20% +$384K 0.99% 25
2022
Q3 		$1.67M Sell
12,476
-40
-0.3% -$5.74K 0.71% 26
2022
Q2 		$1.92M Buy
12,516
+11,077
+770% +$1.69M 0.7% 35
2022
Q1 		$233K Sell
1,439
-11,317
-89% -$1.64M 0.09% 68
2021
Q4 		$1.73M Sell
12,756
-43
-0.3% -$5.08K 0.59% 37
2021
Q3 		$1.38M Buy
12,799
+2,650
+26% +$303K 0.46% 40
2021
Q2 		$1.14M Sell
10,149
-469
-4% -$52.8K 0.36% 50
2021
Q1 		$1.15M Buy
10,618
+94
+0.9% +$10.1K 0.39% 45
2020
Q4 		$1.13M Sell
10,524
-599
-5% -$57.6K 0.41% 45
2020
Q3 		$974K Sell
11,123
-723
-6% -$68.1K 0.39% 47
2020
Q2 		$1.16M Sell
11,846
-2,331
-16% -$205K 0.42% 37
2020
Q1 		$1.08M Buy
+14,177
New +$1.21M 0.49% 36
2019
Q3 		– Sell
-3,950
Closed -$287K – 74
2019
Q2 		$287K Buy
3,950
+1,415
+56% +$111K 0.13% 59
2019
Q1 		$204K Buy
+2,535
New +$207K 0.09% 58

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Financial Sense Advisors's ABBV Position: Q1 2026 in Review

Financial Sense Advisors reduced its AbbVie (ABBV) stake by 0.03% in Q1 2026, selling an estimated $222 and leaving 3,008 shares worth $654K. The position accounts for 0.13% of the portfolio, ranked #90.

Financial Sense Advisors first reported a position in ABBV in Q1 2019 and has held it in 27 quarters since. The position peaked at $3.5M in Q3 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Financial Sense Advisors held 3,008 shares of AbbVie worth $654K as of Q1 2026.
  • Financial Sense Advisors sold 1 AbbVie share in Q1 2026, an estimated $222.
  • AbbVie made up 0.13% of Financial Sense Advisors's portfolio in Q1 2026, its #90 holding.
  • Financial Sense Advisors first reported a position in AbbVie in Q1 2019 and has held it in 27 quarters since.
  • Financial Sense Advisors's AbbVie position peaked at $3.5M in Q3 2024.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Financial Sense Advisors's 13F filing for Q1 2026, filed 14 May 2026.